Ranked board
NAD+ by subscription: what a year costs at every company we have priced
NAD+ is sold in this market the way GLP-1s are: a monthly subscription with a headline number and a different number behind it. Three companies here price it as its own product; a fourth sells it inside a longevity plan alongside two other compounds, and that row says so rather than implying an NAD+ quote the company does not publish.
Disclosure: Some links on this site are affiliate or referral links. If you start a treatment or buy a product through them, we may earn a commission at no additional cost to you. Read our full disclosure.
What gets on this board
Every priced row on a published review here that names NAD+, whatever the route of administration. A plan covering NAD+ alongside other compounds at one price is included with the plan stated in the row, because a plan price is not a quote for this compound.
What decides the order
Ranked by true-year cost, cheapest first — the price of one cycle with no commitment, multiplied by the number of times a year it is actually billed. Nothing is pinned, sponsored, or lifted into position.
What the spread looks like
$2,508
Cheapest year
$3,627
Dearest year
$1,119
Between the two
Ranked by what a year actually costs
The advertised column is what the company leads with. The walk-away column is what one cycle costs if you stop after it. The year column is the second of those multiplied by the number of times a year it is genuinely billed — which is thirteen, not twelve, for anyone on a four-week cycle.
Every price was read off the company's own page on the date shown beside it. The capture procedure, and the five ways a price gets captured wrong, are on our methodology page.
Key terms
Show definitions
- Walk-away price
- What one cycle costs at the standing, no-commitment rate — what you pay if you stop after it. Not a prepay tier and not a first-month promotion.
- True year
- The walk-away price multiplied by the number of times it is actually billed in a year: 12 on a calendar-month cycle, 13 on a four-week cycle.
- Advertised price
- The figure the company leads with on its own pricing page. It is shown here beside the price you pay rather than instead of it.
What this board does not tell you
Whether you qualify
Coverage varies by state, and several of these companies serve fewer states than they appear to. Each review names the exclusions its company actually discloses.
Whether the care is good
This is a cost ranking and nothing else. We have not assessed anyone's clinical care, and there is no quality score anywhere on this site.
What your insurer pays
Every figure here is a cash price. What a covered drug costs you depends on your own plan's formulary and deductible, and no public source publishes a per-drug copay.
Whether the price will hold
Plans restructure without notice. Every row carries the date it was read so you can see how old the number is before you rely on it.
Frequently asked questions
Does this board say anything about whether NAD+ works?
No. It ranks what companies charge for it, on the same two price columns as every other board here, and makes no claim about outcomes. There is no efficacy score anywhere on this site, and the evidence question for NAD+ is not one a pricing page should be answering for you.
Why is one row a plan covering three different compounds?
Because it is a real route to NAD+ at a published price and the company sells it that way rather than per compound. Leaving it off would hide an option; including it silently would imply an NAD+-specific figure that company has never published. So it is on the board and the row names the plan.
Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.